Here's some other vaccine news of note for the week.
> Cancer vaccine startup Gritstone Oncology hired Jayant Aphale, Ph.D., as EVP of technical operations. He previously served senior roles at Sarepta, GlaxoSmithKline Vaccines, Acambis and Wyeth Vaccines. Release
> President Donald Trump unveiled a new plan to combat the opioid crisis, including support for research into developing a vaccine for opioid addiction. CNBC article
> The Philippine government will seek congressional permission to use refunds for unused Dengvaxia shots from Sanofi to support related medical needs of those already inoculated. ABS-CBN article
> TapImmune’s shares rose 17% premarket Thursday after the company said its TPIV200 T-cell vaccine did well in a phase 1 study in patients with ovarian and breast cancer. MarketWatch article